Terri
@justterri.bsky.social
KRAS Kickers founder
Resilient Advocate Speaker
Resilient Advocate Speaker
Reposted by Terri
🔬 Lovely time presenting the med onc's perspective on biomarker testing with BWH path fellows
Gr8 disc on test prioritization when limited sample (when in doubt 📞 📧!), how results guide decisions around prognosis/ treatment, & how we discuss reports ("the brilliant Drs _&_ reviewed your path...")!
Gr8 disc on test prioritization when limited sample (when in doubt 📞 📧!), how results guide decisions around prognosis/ treatment, & how we discuss reports ("the brilliant Drs _&_ reviewed your path...")!
January 9, 2025 at 11:09 PM
🔬 Lovely time presenting the med onc's perspective on biomarker testing with BWH path fellows
Gr8 disc on test prioritization when limited sample (when in doubt 📞 📧!), how results guide decisions around prognosis/ treatment, & how we discuss reports ("the brilliant Drs _&_ reviewed your path...")!
Gr8 disc on test prioritization when limited sample (when in doubt 📞 📧!), how results guide decisions around prognosis/ treatment, & how we discuss reports ("the brilliant Drs _&_ reviewed your path...")!
Reposted by Terri
Had the pleasure of working JulieBrahmer and BrendonStiles with Medscape on a recent activity designed to help you learn more about IO in NSCLC. www.medscape.org/viewarticle/...
The Immunotherapy Mosaic in NSCLC: Pioneering Treatment Frontiers From Early to Advanced Stages
Get the latest information on the use of immune checkpoint inhibitors across the non-small cell lung cancer (NSCLC) disease continuum!
www.medscape.org
November 21, 2024 at 3:25 PM
Had the pleasure of working JulieBrahmer and BrendonStiles with Medscape on a recent activity designed to help you learn more about IO in NSCLC. www.medscape.org/viewarticle/...
Reposted by Terri
First post on here, hopefully an auspicious start :) Pleased to share our perspective article in Frontiers in Oncology is available online today: www.frontiersin.org/journals/onc...
Frontiers | The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways
www.frontiersin.org
November 22, 2024 at 2:33 PM
First post on here, hopefully an auspicious start :) Pleased to share our perspective article in Frontiers in Oncology is available online today: www.frontiersin.org/journals/onc...